{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T14:01:29Z","timestamp":1780408889575,"version":"3.54.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:00:00Z","timestamp":1772841600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","award":["90356657"],"award-info":[{"award-number":["90356657"]}],"id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ad.2026.104609","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T16:25:19Z","timestamp":1773073519000},"page":"104609","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Consensus Document on the Clinical Management of Alopecia Areata: Recommendations from the Spanish Hair Research Group of the Spanish Academy of Dermatology and Venerology"],"prefix":"10.1016","volume":"117","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6315-5462","authenticated-orcid":false,"given":"D.","family":"Saceda-Corralo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Arias-Santiago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Barrutia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Combalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"del Boz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Garnacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Lobato-Berezo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Va\u00f1\u00f3-Galv\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ad.2026.104609_bib0230","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jaad.2019.08.032","article-title":"Epidemiology of alopecia areata, ophiasis, totalis, and universalis: a systematic review and meta-analysis","volume":"82","author":"Lee","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2026.104609_bib0235","doi-asserted-by":"crossref","first-page":"628","DOI":"10.4065\/70.7.628","article-title":"Incidence of alopecia areata in Olmsted County Minnesota, 1975 through 1989","volume":"70","author":"Safavi","year":"1995","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ad.2026.104609_bib0240","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000510880","article-title":"Demographic and clinical features of 1,641 patients with alopecia areata, alopecia totalis, and alopecia universalis: a single-center retrospective study","volume":"7","author":"Uzuncakmak","year":"2021","journal-title":"Skin Appendage Disord"},{"key":"10.1016\/j.ad.2026.104609_bib0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2017.04.1141","article-title":"Alopecia areata: disease characteristics, clinical evaluation, and new perspectives on pathogenesis","volume":"78","author":"Strazzulla","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2026.104609_bib0250","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1529-8019.2011.01413.x","article-title":"Alopecia areata: clinical presentation, diagnosis, and unusual cases","volume":"24","author":"Finner","year":"2011","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.ad.2026.104609_bib0255","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/ijd.13612","article-title":"Review of treatment for alopecia totalis and alopecia universalis","volume":"56","author":"Kassira","year":"2017","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.ad.2026.104609_bib0260","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1111\/jdv.18926","article-title":"The burden of alopecia areata: a scoping review focusing on quality of life, mental health and work productivity","volume":"37","author":"Muntyanu","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ad.2026.104609_bib0265","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1111\/jdv.18733","article-title":"Prevalence and implications of type D personality in patients with alopecia areata: a marker of quality-of-life impairment and mood status disturbances, a comparative study","volume":"37","author":"S\u00e1nchez-D\u00edaz","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ad.2026.104609_bib0270","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1046\/j.1365-2133.2003.05535.x","article-title":"Guidelines for the management of alopecia areata","volume":"149","author":"MacDonald Hull","year":"2003","journal-title":"Br J Dermatol"},{"issue":"suppl 1","key":"10.1016\/j.ad.2026.104609_bib0275","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1046\/j.1365-4362.1999.00004.x","article-title":"Alopecia areata: diagnosis and management","volume":"38","author":"Shapiro","year":"1999","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.ad.2026.104609_bib0280","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jaad.2009.10.032","article-title":"Alopecia areata update: part I. Clinical picture, histopathology, and pathogenesis","volume":"62","author":"Alkhalifah","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2026.104609_bib0285","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jaad.2003.09.032","article-title":"Alopecia areata investigational assessment guidelines \u2013 Part II","volume":"51","author":"Olsen","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2026.104609_bib0290","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/pde.15378","article-title":"Efficacy and safety of ritlecitinib in adolescents with alopecia areata: results from the ALLEGRO phase 2b\/3 randomized, double-blind, placebo-controlled trial","volume":"40","author":"Hordinsky","year":"2023","journal-title":"Pediatr Dermatol"},{"issue":"10387","key":"10.1016\/j.ad.2026.104609_bib0295","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/S0140-6736(23)00222-2","article-title":"Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b\u20133 trial","volume":"401","author":"King","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.ad.2026.104609_bib0300","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jaad.2021.03.050","article-title":"A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results","volume":"85","author":"King","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2026.104609_bib0305","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1056\/NEJMoa2110343","article-title":"Two phase 3 trials of baricitinib for alopecia areata","volume":"386","author":"King","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ad.2026.104609_bib0310","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1136\/bmj.311.7001.376","article-title":"Consensus methods for medical and health services research","volume":"311","author":"Jones","year":"1995","journal-title":"BMJ"},{"key":"10.1016\/j.ad.2026.104609_bib0315","series-title":"Oxford Centre for Evidence-Based Medicine: Levels of Evidence (March 2009)","year":"2009"},{"key":"10.1016\/j.ad.2026.104609_bib0320","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.jaad.2015.12.026","article-title":"Pulse corticosteroid therapy with oral dexamethasone for the treatment of adult alopecia totalis and universalis","volume":"74","author":"Va\u00f1\u00f3-Galv\u00e1n","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2026.104609_bib0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2018.06.064","article-title":"Methotrexate for alopecia areata: a systematic review and meta-analysis","volume":"80","author":"Phan","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2026.104609_bib0330","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s13555-020-00370-2","article-title":"Cyclosporine with and without systemic corticosteroids in treatment of alopecia areata: a systematic review","volume":"10","author":"Nowaczyk","year":"2020","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1016\/j.ad.2026.104609_bib0335","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/j.1365-4632.2010.04576.x","article-title":"Could azathioprine be considered as a therapeutic alternative in the treatment of alopecia areata? A pilot study","volume":"49","author":"Farshi","year":"2010","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.ad.2026.104609_bib0340","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.jaad.2015.12.055","article-title":"Treatment of recalcitrant adult alopecia areata universalis with oral azathioprine","volume":"74","author":"Va\u00f1\u00f3-Galv\u00e1n","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2026.104609_bib0345","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1111\/jocd.14687","article-title":"Comparative study between the efficacies of azathioprine and mesalazine in the treatment of severe alopecia areata","volume":"21","author":"Mahgoob","year":"2022","journal-title":"J Cosmet Dermatol"},{"key":"10.1016\/j.ad.2026.104609_bib0350","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4103\/ijt.ijt_14_18","article-title":"Mesalazine in the treatment of extensive alopecia areata: a new therapeutic option?","volume":"10","author":"Kiszewski","year":"2018","journal-title":"Int J Trichology"},{"key":"10.1016\/j.ad.2026.104609_bib0355","unstructured":"Ficha Tecnica Olumiant 4 mg Comprimidos Recubiertos con Pelicula. Available from: https:\/\/cima.aemps.es\/cima\/dochtml\/ft\/1161170010\/FT_1161170010.html. Accessed 2 December 2024."},{"key":"10.1016\/j.ad.2026.104609_bib0360","unstructured":"Ficha Tecnica Litfulo 50 mg Capsulas Duras. Available from: https:\/\/cima.aemps.es\/cima\/dochtml\/ft\/1231755002\/FT_1231755002.html. Accessed 2 December 2024."},{"key":"10.1016\/j.ad.2026.104609_bib0365","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/pde.15684","article-title":"\u2018I need to understand so we can decide together\u2019: difficult conversations about alopecia areata","volume":"41","author":"Tissera","year":"2024","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.ad.2026.104609_bib0370","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1111\/bjd.17463","article-title":"Living with alopecia areata: an online qualitative survey study","volume":"180","author":"Davey","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2026.104609_bib0375","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s13555-021-00512-0","article-title":"Patient perspectives of the social emotional and functional impact of alopecia areata: a systematic literature review","volume":"11","author":"Mostaghimi","year":"2021","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1016\/j.ad.2026.104609_bib0380","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/bjd.14497","article-title":"Alopecia areata and health-related quality of life: a systematic review and meta-analysis","volume":"175","author":"Rencz","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2026.104609_bib0385","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1001\/jamadermatol.2023.5869","article-title":"The alopecia areata severity and morbidity index (ASAMI) study: results from a global expert consensus exercise on determinants of alopecia areata severity","volume":"160","author":"Moussa","year":"2024","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ad.2026.104609_bib0390","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s13555-021-00648-z","article-title":"Validation of the Alopecia Areata Patient Priority Outcomes (AAPPO) Questionnaire in adults and adolescents with alopecia areata","volume":"12","author":"Wyrwich","year":"2022","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1016\/j.ad.2026.104609_bib0395","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s13555-022-00711-3","article-title":"Defining severity in alopecia areata: current perspectives and a multidimensional framework","volume":"12","author":"King","year":"2022","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1016\/j.ad.2026.104609_bib0400","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jaad.2021.08.043","article-title":"Development of the alopecia areata scale for clinical use: results of an academic\u2013industry collaborative effort","volume":"86","author":"King","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2026.104609_bib0405","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.jaad.2019.11.066","article-title":"Efficacy of different concentrations of intralesional triamcinolone acetonide for alopecia areata: a systematic review and meta-analysis","volume":"82","author":"Yee","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2026.104609_bib0410","doi-asserted-by":"crossref","DOI":"10.1111\/dth.14526","article-title":"A linear forehead lesion caused by intralesional injection of triamcinolone acetonide and treated with hyaluronic acid filler: case report","volume":"33","author":"Piccolo","year":"2020","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.ad.2026.104609_bib0415","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1529-8019.2011.01419.x","article-title":"Topical and intralesional therapies for alopecia areata","volume":"24","author":"Alkhalifah","year":"2011","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.ad.2026.104609_bib0420","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/j.jisp.2020.04.005","article-title":"JAK Inhibitors for the treatment of pediatric alopecia areata","volume":"20","author":"Hamilton","year":"2020","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1016\/j.ad.2026.104609_bib0425","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.jaad.2021.04.077","article-title":"Treatment of pediatric alopecia areata: a systematic review","volume":"86","author":"Barton","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2026.104609_bib0430","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/j.jaad.2023.05.049","article-title":"Janus kinase inhibitors for alopecia areata","volume":"89","author":"King","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2026.104609_bib0435","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/jdv.19768","article-title":"European expert consensus statement on the systemic treatment of alopecia areata","volume":"38","author":"Rudnicka","year":"2024","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ad.2026.104609_bib0440","doi-asserted-by":"crossref","DOI":"10.1111\/dth.15062","article-title":"Less is more? Failure of one JAK inhibitor does not predict failure of another one in a patient with alopecia areata","volume":"34","author":"Peterson","year":"2021","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.ad.2026.104609_bib0445","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/jdv.15489","article-title":"JAK inhibitors for alopecia areata: a systematic review and meta-analysis","volume":"33","author":"Phan","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ad.2026.104609_bib0450","doi-asserted-by":"crossref","first-page":"465","DOI":"10.4103\/idoj.idoj_452_22","article-title":"Which is the ideal JAK inhibitor for alopecia areata \u2013 baricitinib, tofacitinib ritlecitinib or ifidancitinib \u2013 revisiting the immunomechanisms of the JAK pathway","volume":"14","author":"Sardana","year":"2023","journal-title":"Indian Dermatol Online J"}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731026000190?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731026000190?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T13:03:47Z","timestamp":1780405427000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001731026000190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0001731026000190"],"URL":"https:\/\/doi.org\/10.1016\/j.ad.2026.104609","relation":{},"ISSN":["0001-7310"],"issn-type":[{"value":"0001-7310","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Consensus Document on the Clinical Management of Alopecia Areata: Recommendations from the Spanish Hair Research Group of the Spanish Academy of Dermatology and Venerology","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2026.104609","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 AEDV. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"104609"}}